undamentalytics Newsletter
Sign in

National Healthcare Properties, Inc. (NHP) stock

Add to watchlist

Add holding +

NASDAQ: NHP Nasdaq Health Care REITs Next results ~November 4, 2026

E Fundamentals grade

National Healthcare Properties, Inc. is a US-listed company in the health care REITs industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Model estimate per share

~$9.2

Funds-from-operations model

Base case. Range ~$7.7–$11. Funds from operations growing 2.5% a year, discounted at 8%.

Price vs value

No Buy/Hold/Sell rating is issued: only 1 valuation models apply; a rating needs 3.

National Healthcare Properties, Inc. valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Funds93 adding, 0 cuttingOf 22 active managers that changed their stake, 22 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter National Healthcare Properties files

Where National Healthcare Properties stands after its latest 10-Q

Revenue for the twelve months to June 2026 was $344m, down 1.2% on a year earlier, a smaller fall than the 2.8% decline a quarter earlier. That puts it 15 of 17 for growth among the health care reits companies we cover. The diluted share count is up 29.5% on a year earlier, which dilutes existing holders. Our funds-from-operations model value is $4.22 a share, against a share price of $15.08.

Source: 10-Q filed August 6, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~November 4, 2026 (estimated)

National Healthcare Properties, Inc.'s trailing-twelve-month revenue fell 1.2% year on year, with a free-cash-flow margin of 6.9%. Where it lags: operating margin of 3.2% ranks 5 of 5 health care reits companies we cover.

Current signal Results well ahead of expectations: Reported earnings per share beat the analysts' consensus estimate by 39% in the quarter to 2026-06-30.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Margins widening. Operating margin is up 7.3 points on a year ago.
  • Net cash. Cash exceeds long-term debt by $0.2bn.
  • Estimates rising. Analysts' consensus for next year's earnings per share has risen 407.7% over 90 days.

Things to watch

  • Revenue shrinking. Revenue fell 1.2% over the last 12 months.
  • Share dilution. Diluted shares rose 29.5% in a year.
  • Below peers: operating margin. Operating margin of 3.2% ranks 5 of 5 health care reits companies we cover (median 35.3%).
  • Below peers: net margin. Net margin of -16.7% ranks 17 of 17 health care reits companies we cover (median 7.8%).
  • Earnings expected to fall. The consensus expects earnings per share to fall 53% next year.

Latest results: FY2026 Q2

Filed August 6, 2026
Earnings per share
-$0.07 against an average estimate of -$0.11: beat by 38.8%
Revenue
$88m, up 2.6% on a year earlier
Share reaction
+8.1% in the first session after the results on August 5, 2026, against -0.4% for the S&P 500
Next report
November 4, 2026; average EPS estimate $0.41

National Healthcare Properties' figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day+0.1%
  • 1 week-1.2%
  • 1 month-5.7%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$344M
Operating margin
3.2%
Net margin
-16.7%
EPS (TTM, diluted)
$-1.57

Growth

Revenue growth
−1.2%
Change in growth rate
+1.6 pts
Share count change
+29.5%

Earnings

Last results
August 5, 2026

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Announcement
  2. Agreement
  3. Leadership
  4. Deal
  5. Results
  6. Leadership

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

National Healthcare Properties, Inc. valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: only 1 valuation models apply; a rating needs 3.

Valuation models

We value National Healthcare Properties, Inc. as an equity reit, with every model that fits that kind of business. Cost of equity 8%: the 10-year Treasury yield (4.9%) plus a beta of 0.67 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Funds-from-operations model Funds from operations growing 2.5% a year, discounted at 8%. ~$9.2 ~$7.7–$11 Primary model, counts double
Price-to-FFO vs peers Funds from operations per share times peers' typical (harmonic-mean) price-to-FFO. ~$0.2 ~$4.1–$8.5 Left out: out of range vs price (0.01x)
Dividend discount (growing dividend) Today's dividend growing 2.5% a year, discounted at the cost of equity. — Does not apply: no current dividend figure in the company's tagged filings
Combined value Weighted average of the models that apply: the primary model (funds-from-operations model) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$9.2 ~$7.7–$11 1 model

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare National Healthcare Properties, Inc. with equity REITs in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Moat

43 /100

Weak moat

How hard National Healthcare Properties's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 0 / 20

    Net income has been a median -3.3% of total assets over 10 years.

  • Pricing power 13 / 20

    Gross margin has been a median 37.0%, moving by 1.4 percentage points (standard deviation) across 10 years.

  • Durability 10 / 20

    Operating margin has been a median -2.6%; its worst year was -31.2%.

  • Cash conversion 10 / 20

    Free cash flow was positive in 7 of 10 years, at a median 5.6% of revenue.

  • Discipline 10 / 20

    The diluted share count rose 55.5% over five years; stock-based pay has been a median 0.3% of revenue.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: November 4, 2026, after the close. Analysts expect revenue of $95m and EPS of $0.41 (range −$0.01 to $0.83) for the quarter.

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $0.47 — $362m —
Next $0.22 −53% $354m −2%

Next year's EPS estimate has moved +407.7% in 90 days, across 1 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is +20.5% on 90 days ago. In the last 30 days, 0 analysts raised National Healthcare Properties, Inc.'s forecast and 0 cut it.

Consensus EPS forecast National Healthcare Properties, Inc., last 90 days
$0.00 $0.20 $0.40 $0.60 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: $0.39 Current fiscal year, 60 days ago: $0.04 Current fiscal year, 30 days ago: $0.18 Current fiscal year, 7 days ago: $0.20 Current fiscal year, Now: $0.47 $0.47 Next fiscal year, 90 days ago: $0.04 Next fiscal year, 60 days ago: $0.07 Next fiscal year, 30 days ago: $0.05 Next fiscal year, 7 days ago: $0.07 Next fiscal year, Now: $0.22 $0.22

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago $0.39$0.04
60 days ago $0.04$0.07
30 days ago $0.18$0.05
7 days ago $0.20$0.07
Now $0.47$0.22

Earnings against estimates

Quarter toEstimateActualSurprise
Jun 2026 −$0.11 −$0.07 +38.8%

Adjusted EPS as companies report it, against the average analyst estimate.

Analyst recommendations

8 analysts, Oct 2026
Buy563%
Hold338%
Sell00%

Monthly trend

  1. Oct 20262338
  2. Sep 20261348
  3. Aug 20261348
  4. Jul 20261348

Counts of recommendations published by analysts covering National Healthcare Properties, Inc., by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
8.3%
of tradable shares
Days to cover
4.25
at average volume
Short interest, 1 month
−5%
to October 15, 2026
Held by institutions
75%
of shares
Held by insiders
0.0%
of shares
Employees
31
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

Price behaviour

52-week range
Not enough history
From 52-week high
—
vs 50-day average
−4.0%
vs 200-day average
—
Volatility (1 year)
35%
Beta vs S&P 500
-0.11

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
2 up, 0 down
typical move ±8.0%
After a week
2 up, 0 down
typical move ±5.9%
After a month
2 up, 0 down
typical move ±4.3%
Results releasedNext dayS&P 500 next day5 days21 days
August 5, 2026 +8.1% −0.4% +3.7% +2.7%
May 13, 2026 +7.9% +1.4% +8.2% +5.9%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

National Healthcare Properties, Inc. in five measures

Fundamentals grade E
Growth Profitability Cash Balance sheet

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) National Healthcare Properties, Inc.
$340M $345M $350M $355M FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue (TTM), FY23 Q3: $344.1M Revenue (TTM), FY23 Q4: $345.9M Revenue (TTM), FY24 Q1: $346.9M Revenue (TTM), FY24 Q2: $349.6M Revenue (TTM), FY24 Q3: $352.8M Revenue (TTM), FY24 Q4: $353.8M Revenue (TTM), FY25 Q1: $351.9M Revenue (TTM), FY25 Q2: $348.5M Revenue (TTM), FY25 Q3: $345.5M Revenue (TTM), FY25 Q4: $342.3M Revenue (TTM), FY26 Q1: $342.1M Revenue (TTM), FY26 Q2: $344.3M $344.3M

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue (TTM)
FY23 Q3 $344.1M
FY23 Q4 $345.9M
FY24 Q1 $346.9M
FY24 Q2 $349.6M
FY24 Q3 $352.8M
FY24 Q4 $353.8M
FY25 Q1 $351.9M
FY25 Q2 $348.5M
FY25 Q3 $345.5M
FY25 Q4 $342.3M
FY26 Q1 $342.1M
FY26 Q2 $344.3M
Revenue growth, TTM YoY National Healthcare Properties, Inc.
-4% -2% 0% 2% 4% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue growth, TTM YoY, FY23 Q3: 3.1% Revenue growth, TTM YoY, FY23 Q4: 3.0% Revenue growth, TTM YoY, FY24 Q1: 2.2% Revenue growth, TTM YoY, FY24 Q2: 2.3% Revenue growth, TTM YoY, FY24 Q3: 2.6% Revenue growth, TTM YoY, FY24 Q4: 2.3% Revenue growth, TTM YoY, FY25 Q1: 1.5% Revenue growth, TTM YoY, FY25 Q2: -0.3% Revenue growth, TTM YoY, FY25 Q3: -2.1% Revenue growth, TTM YoY, FY25 Q4: -3.3% Revenue growth, TTM YoY, FY26 Q1: -2.8% Revenue growth, TTM YoY, FY26 Q2: -1.2% -1.2%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q3 3.1%
FY23 Q4 3.0%
FY24 Q1 2.2%
FY24 Q2 2.3%
FY24 Q3 2.6%
FY24 Q4 2.3%
FY25 Q1 1.5%
FY25 Q2 -0.3%
FY25 Q3 -2.1%
FY25 Q4 -3.3%
FY26 Q1 -2.8%
FY26 Q2 -1.2%
Operating margin (TTM) National Healthcare Properties, Inc.
-40% -30% -20% -10% 0% 10% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Operating margin (TTM), FY23 Q3: -0.8% Operating margin (TTM), FY23 Q4: -1.4% Operating margin (TTM), FY24 Q1: -2.2% Operating margin (TTM), FY24 Q2: -31.2% Operating margin (TTM), FY24 Q3: -36.6% Operating margin (TTM), FY24 Q4: -34.9% Operating margin (TTM), FY25 Q1: -31.1% Operating margin (TTM), FY25 Q2: -4.2% Operating margin (TTM), FY25 Q3: 2.6% Operating margin (TTM), FY25 Q4: 1.0% Operating margin (TTM), FY26 Q1: 0.1% Operating margin (TTM), FY26 Q2: 3.2% 3.2%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Operating margin (TTM)
FY23 Q3 -0.8%
FY23 Q4 -1.4%
FY24 Q1 -2.2%
FY24 Q2 -31.2%
FY24 Q3 -36.6%
FY24 Q4 -34.9%
FY25 Q1 -31.1%
FY25 Q2 -4.2%
FY25 Q3 2.6%
FY25 Q4 1.0%
FY26 Q1 0.1%
FY26 Q2 3.2%
FCF margin (TTM) National Healthcare Properties, Inc.
-40% -20% 0% 20% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 FCF margin (TTM), FY23 Q3: -0.5% FCF margin (TTM), FY23 Q4: -0.2% FCF margin (TTM), FY24 Q1: -1.4% FCF margin (TTM), FY24 Q2: -1.3% FCF margin (TTM), FY24 Q3: -30.0% FCF margin (TTM), FY24 Q4: -28.8% FCF margin (TTM), FY25 Q1: -35.8% FCF margin (TTM), FY25 Q2: -35.9% FCF margin (TTM), FY25 Q3: -5.5% FCF margin (TTM), FY25 Q4: -6.4% FCF margin (TTM), FY26 Q1: 2.6% FCF margin (TTM), FY26 Q2: 6.9% 6.9%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q3 -0.5%
FY23 Q4 -0.2%
FY24 Q1 -1.4%
FY24 Q2 -1.3%
FY24 Q3 -30.0%
FY24 Q4 -28.8%
FY25 Q1 -35.8%
FY25 Q2 -35.9%
FY25 Q3 -5.5%
FY25 Q4 -6.4%
FY26 Q1 2.6%
FY26 Q2 6.9%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-K/A, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2013 Dec 2013 2014 Dec 2014 2015 Dec 2015 2016 Dec 2016 2017 Dec 2017 2018 Dec 2018 2019 Dec 2019 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Jun 2026
Income
Revenue 2 58 247 303 311 362 375 382 329 336 346 354 342 344
Gross profit 2 32 122 130 125 141 141 138 124 122 128 132 123 130
EBITDA 1 −5 85 96 65 80 49 61 42 51 78 −39 82 83
Operating income −0 −34 −36 −3 −12 −3 −32 −20 −37 −32 −5 −124 3 11
Net income −0 −38 −42 −21 −43 −53 −88 −79 −93 −93 −86 −203 −71 −58
Diluted EPS −$0.39 −$2.92 −$1.93 −$0.95 −$1.85 −$2.21 −$3.47 −$2.92 −$3.23 −$3.30 −$3.04 −$7.19 −$2.51 −$1.57
Growth (year on year)
Revenue — +>999% +323.5% +22.3% +2.8% +16.5% +3.5% +1.8% −13.7% +2.0% +3.0% +2.3% −3.3% −1.2%
EBITDA — −732.1% — +12.0% −31.5% +22.3% −38.5% +24.2% −30.5% +18.9% +54.7% −150.5% — +19.3%
Margins
Gross margin 93.3% 54.3% 49.3% 43.1% 40.1% 39.0% 37.5% 36.2% 37.5% 36.4% 37.0% 37.4% 36.0% 37.9%
EBITDA margin 47.4% −9.3% 34.5% 31.6% 21.0% 22.1% 13.1% 16.0% 12.9% 15.0% 22.6% −11.2% 23.8% 24.0%
Operating margin −11.9% −58.7% −14.4% −1.1% −3.9% −0.9% −8.5% −5.2% −11.4% −9.4% −1.4% −34.9% 1.0% 3.2%
Net margin −12.2% −64.5% −16.9% −6.9% −13.7% −14.6% −23.5% −20.6% −28.2% −27.8% −24.9% −57.5% −20.8% −16.7%
Free-cash-flow margin −42.0% −12.4% 25.0% 23.5% 17.9% 11.4% 8.2% 5.2% 6.0% 0.1% −0.2% −28.8% −6.4% 6.9%
Cash flow
Cash from operations −1 −6 69 79 64 54 47 42 39 28 22 −80 7 51
Capital spending 0 1 7 7 8 13 17 22 19 28 22 22 29 27
Free cash flow −1 −7 62 71 56 41 31 20 20 0 −1 −102 −22 24
Stock-based pay 0 0 0 0 0 1 1 1 1 1 1 1 4 5
Free cash flow after stock pay −1 −7 62 71 55 40 29 19 18 −1 −2 −102 −26 18
Balance sheet
Cash 112 183 24 29 94 77 96 72 60 54 46 22 58 246
Total debt 0 66 157 143 407 463 1,147 1,229 1,097 1,117 1,182 1,152 1,046 857
Net debt (negative = net cash) −112 −117 133 114 312 386 1,052 1,157 1,037 1,064 1,136 1,130 989 611
Diluted shares — 13m 22m 22m 23m 24m 25m 27m 29m 28m 28m 28m 28m 37m
Returned to shareholders
Dividends 1 35 66 75 77 55 51 31 0 0 — — — —
Buybacks 0 1 10 12 34 14 21 11 0 0 — — — —
Total returned 1 36 77 88 110 70 73 42 0 0 — — — —

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Dividends, buybacks and capital spending

Diluted share count
+29.5%
year over year

Competitors: side by side with peers

Closest by revenue in health care reits
Last 12 months unless stated NHP LTC DEA NHI CTRE STRW Median
Revenue, last 12 months $344m $348m $365m $432m $571m $160m $919m
Revenue growth, last 12 months −1.2% 59.8% 11.4% 23.9% 53.0% 18.3% 15.0%
Revenue growth, 3-year average 0.2% 22.5% 8.2% 12.0% 40.9% 18.4% 12.0%
Revenue growth, latest quarter 2.6% 64.1% 8.7% 33.8% 43.5% 5.8% 11.1%
Gross margin 37.9% — 77.2% — 100.0% — 60.1%
Operating margin 3.2% 62.6% 19.7% 58.1% — 54.5% 35.3%
Operating margin, 3-year average −10.7% 83.2% 15.9% 67.9% — 53.0% 35.7%
Net margin −16.7% 38.9% 4.0% 38.6% 62.2% 5.3% 7.8%
Cash from operations / revenue 14.7% 40.7% 44.2% 57.5% 78.2% 51.9% 41.7%
Free-cash-flow margin 6.9% 37.5% 9.7% 36.5% 58.3% 25.9% 15.1%
Free-cash-flow margin, 3-year average −10.1% 47.6% 23.6% 39.0% 59.7% 27.7% 19.1%
Stock pay / revenue 1.6% 2.5% 2.1% 1.5% 2.0% 2.1% 1.6%
Change in share count 29.5% 7.4% 6.1% 5.7% 23.8% 31.7% 6.1%

Median of all 17 companies we cover in health care reits. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

17 health care reits companies
Measure Company Peer median Rank
Revenue growth Growth -1.2% 15.0% 15 of 17
Change in growth rate Growth +1.6pp +1.1pp 8 of 17
Operating margin Profitability 3.2% 35.3% 5 of 5
Net margin Profitability -16.7% 7.8% 17 of 17
Stock pay as % of revenue Cash generation 1.6% 1.8% 8 of 16
Change in share count Balance sheet 29.5% 6.1% 16 of 17

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Where the revenue comes from

Fiscal year to December 31, 2025
Segments
Line of business Revenue Share YoY
Seniors Housing Communities $225M 65.8% ▲ 4.0%
Outpatient Medical Facilities $117M 34.2% ▼ 14.8%

From National Healthcare Properties, Inc.'s 10-K filed February 20, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$778M
Institutions reporting
93
Positions opened / closed
93 / 0

Top buyers and sellers, Q2 2026: 93 institutions bought and 0 sold ; the biggest buyer was Principal Financial Group Inc (+4.9M shares) . See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Principal Financial Group Inc $72.2M 4.9M 9.3% —
Alliancebernstein L.P. $71.7M 4.9M 9.2% —
Prudential Financial Inc $66M 4.5M 8.5% —
Duff & Phelps Investment Management Co $60.5M 4.1M 7.8% —
Blackrock, Inc. $56.2M 3.8M 7.2% —
Lasalle Investment Management Securities LLC $49.1M 3.4M 6.3% —
Zimmer Partners, LP $44.4M 3.0M 5.7% —
Rush Island Management, LP $37.8M 2.6M 4.9% —
Alyeska Investment Group, L.P. $37.3M 2.5M 4.8% —
FMR LLC $33.6M 2.3M 4.3% —
Sumitomo Mitsui Trust Group, Inc. $25.5M 1.7M 3.3% —
Vanguard Capital Management LLC $24.9M 1.7M 3.2% —

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not National Healthcare Properties, Inc.'s complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $0 0 trades by 0 insiders, last 12 months Insider sales History → $0 0 trades by 0 insiders
Net ▲ $0 net buying

No open-market insider trades reported in the last 12 months.

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

Next expected around October 28, 2026 estimated from the company's past filing pattern, not announced

  • August 5, 2026
  • May 13, 2026
  • April 13, 2026
  • February 20, 2026
  • November 5, 2025
  • August 7, 2025

Recent SEC filings

Data status

When each part of this page on National Healthcare Properties, Inc. was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

National Healthcare Properties, Inc. in brief

What does National Healthcare Properties, Inc. do?
National Healthcare Properties, Inc. is a US-listed company in the health care REITs industry. Its financial year ends in December.
What is National Healthcare Properties, Inc.'s stock ticker?
National Healthcare Properties, Inc. trades under the ticker NHP on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is National Healthcare Properties, Inc.'s revenue, and how fast is it growing?
Over its most recent trailing twelve months, National Healthcare Properties, Inc. reported revenue of $344M, 1.2% lower than a year earlier, according to its SEC filings.
What is National Healthcare Properties, Inc.'s free cash flow?
National Healthcare Properties, Inc.'s free-cash-flow margin is 6.9% of revenue over the trailing twelve months.
Who are National Healthcare Properties, Inc.'s largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Principal Financial Group Inc, Alliancebernstein L.P. and Prudential Financial Inc. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
What is National Healthcare Properties, Inc.'s market cap?
On November 2, 2026, National Healthcare Properties, Inc.'s market capitalisation was about $553M and net debt of $611M. Market figures come from third-party market data and may be delayed.
Who are National Healthcare Properties, Inc.'s competitors?
In our Health Care REITs peer group, the companies closest to National Healthcare Properties, Inc. are LTC Properties Inc, Easterly Government Properties, Inc., National Health Investors Inc, Caretrust Reit, Inc. and Strawberry Fields Reit, Inc. The side-by-side comparison below sets their revenue, margins and growth against National Healthcare Properties, Inc.'s.
When is National Healthcare Properties, Inc.'s next earnings date?
Around November 4, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — National Healthcare Properties, Inc. announces its own schedule.